Updated Results From The Ongoing Phase 1 Study Of Elranatamab, A Bcma Targeted T-Cell Redirecting Immunotherapy, For Patients With Relapsed Or Refractory Multiple Myeloma
Elranatamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Updated Results From The Ongoing Phase 1 Study Of Elranatamab, A Bcma Targeted T-Cell Redirecting Immunotherapy, For Patients With Relapsed Or Refractory Multiple Myeloma ### Output: Elranatamab